# Regeneron Pharmaceuticals, Inc.: Form 4, filed Jun 6, 2017

- Company: [Regeneron Pharmaceuticals, Inc.](/companies/regn.md) (CIK 872589)
- Form: 4
- Filed: 2017-06-06
- Accepted by EDGAR: Jun 6, 2017, 17:00 ET
- Period: 2017-06-02
- Accession: 0001140361-17-023988
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/872589/000114036117023988/xslF345X03/form4.xml
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/872589/000114036117023988/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/872589/000114036117023988/xslF345X03/form4.xml

Filed Jun 6, 2017.
Source: SEC EDGAR, the filing index for accession 0001140361-17-023988. Last ingested by Listed: Nov 6, 2026, 16:27 ET. No prices; not investment advice.